Citation Impact

Citing Papers

Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients
1996
The Stability Landscape of de novo TIM Barrels Explored by a Modular Design Approach
2021 StandoutNobel
Caffeinated energy drinks—A growing problem
2008 Standout
Regulation of Oligodendrocyte Development and CNS Myelination by Growth Factors: Prospects for Therapy of Demyelinating Disease
1996
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
2008 Standout
Focal application of neutralizing antibodies to soluble neurotrophic factors reduces collateral axonal branching after peripheral nerve lesion
2002
Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans
1996
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Trophic Support of Motoneurons: Physiological, Pathophysiological, and Therapeutic Implications
1993
Natural products: An evolving role in future drug discovery
2011 Standout
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
2001 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Validation of the Karolinska sleepiness scale against performance and EEG variables
2006 Standout
Anti-Escherichia Coli Adhesin Activity of Cranberry and Blueberry Juices
1996
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
2001 Standout
Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine
2009 StandoutNobel
Antimicrobial properties of phenolic compounds from berries
2001 Standout
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
S100β prevents the death of motor neurons in newborn rats after sciatic nerve section
1997
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
2006
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
2001
Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study
1991
The Use of Stimulants to Modify Performance During Sleep Loss: A Review by the Sleep Deprivation and Stimulant Task Force of the American Academy of Sleep Medicine
2005
Corneal nerves: structure, contents and function
2003 Standout
Secretion of Recombinant Human Insulin-Like Growth Factor I (IGF-I)
1998
Effect of Modafinil at Steady State on the Single‐Dose Pharmacokinetic Profile of Warfarin in Healthy Volunteers
2002
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Biomedical applications of collagen
2001 Standout
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
1988
Mixed lineage kinase–c‐jun N‐terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease
2005
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
2001 Standout
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Heterologous protein expression in the methylotrophic yeastPichia pastoris
2000 Standout
Asymmetric counteranion-directed Lewis acid organocatalysis for the scalable cyanosilylation of aldehydes
2016 StandoutNobel
Neurotrophic factors and neuro-muscular disease: II. GDNF, other neurotrophic factors, and future directions
1999
Asymmetric cyanohydrin synthesis catalyzed by synthetic dipeptides, 1
1979
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
1995 Standout
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
2001 Standout
Advances in the Pharmacotherapy of Attention‐Deficit‐Hyperactivity Disorder: Focus on Methylphenidate Formulations
2003
Fibrin as a component of the tumor stroma: origins and biological significance
1983
Aromatic side‐chain contributions to the far ultraviolet circular dichroism of peptides and proteins
1978
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
2005 Standout
Plant Products as Antimicrobial Agents
1999 Standout
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
Neurotrophins and Neuronal Plasticity
1995 StandoutScience
Modafinil Elicits Sympathomedullary Activation
2005
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
1991
An evaluation of the abuse potential of modafinil using methylphenidate as a reference
2000
Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a Derivatives
1997
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
1988
Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.
1998
Nmr studies of the molecular conformations in the linear oligopeptides H‐(L‐Ala)nL‐Pro‐OH
1976 StandoutNobel
Conformational studies on the hypothalamic thyrotropin releasing factor and related compounds by 1H nuclear magnetic resonance spectroscopy
1974
Tumors: Wounds That Do Not Heal
1986 Standout
Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
2003
Modafinil: new indications for wake promotion
2005
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout

Works of Peter E. Grebow being referenced

Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation.
1975
Single‐Dose Pharmacokinetics of Modafinil and Methylphenidate Given Alone or in Combination in Healthy Male Volunteers
1998
Insulin-like Growth Factor-I: Potential for Treatment of Motor Neuronal Disorders
1993
Comparison of the Single‐Dose Pharmacokinetics and Tolerability of Modafinil and Dextroamphetamine Administered Alone or in Combination in Healthy Male Volunteers
1998
The Potential of Insulin‐like Growth Factor‐I as a Therapeutic for the Treatment of Neuromuscular Disorders
1993
A Double‐Blind, Placebo‐Controlled, Ascending‐Dose Evaluation of the Pharmacokinetics and Tolerability of Modafinil Tablets in Healthy Male Volunteers
1999
Lack of effect of bilateral nephrectomy on the pharmacokinetics of 14C-indapamide (REV 2555) and its metabolites in the dog.
1983
Leukokinin-H generated from human ascites fluid; its isolation and pharmacology
1979
Conformation of histidine model peptides. II. Spectroscopic properties of the imidazole chromophore
1975
Conformation of histidine model peptides. III. Chiroptical properties of cycloL‐alanyl‐L‐histidine and cycloL‐histidinyl‐L‐histidine
1975
Open‐Label, Single‐Dose Pharmacokinetic Study of Modafinil Tablets: Influence of Age and Gender in Normal Subjects
1999
Conformation of histidine model peptides. I. Conformational energy calculations for L‐alanyl‐L‐histidine diketopiperazine
1974
Rankless by CCL
2026